Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity | MicrobiomeTrials← Back to trialsNCT01867411
Multimodal Neuroimaging Genetic Biomarkers of Nicotine AddictionSeverity
CompletedOBSERVATIONAL
Trial Details
Start: 2013-11-06Est. Completion: 2024-06-29
Enrollment target: 159 participants Locations- National Institute on Drug Abuse, Baltimore, Maryland, United States
Other microbiome trials you might be interested in
Nicotine VapingNicotine Use Disorder
Use of vaping products (e.g., electronic nicotine delivery systems, e-cigarettes) has been increasing rapidly, particula…
St Louis, United StatesCompleted Jun 30, 2026
Major Depressive DisorderSubstance Use DisorderNormal Physiology
Background:
Nicotine dependence leads to about 480,000 deaths every year in the United States. People with major depres…
Baltimore, United StatesEst. completion Dec 30, 2027